Tarek S Elkadi, MD - Medicare Anesthesiology in Bangor, ME

Tarek S Elkadi, MD is a medicare enrolled "Anesthesiology" physician in Bangor, Maine. He graduated from medical school in 1994 and has 30 years of diverse experience with area of expertise as Anesthesiology. He is a member of the group practice Eastern Maine Medical Center, St Joseph Hospital, City Of Hope Medical Foundation and his current practice location is 360 Broadway, Bangor, Maine. You can reach out to his office (for appointments etc.) via phone at (207) 262-1464.

Tarek S Elkadi is licensed to practice in Maine (license number MD16476) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1245302736.

Contact Information

Tarek S Elkadi, MD
360 Broadway,
Bangor, ME 04401-3979
(207) 262-1464
Not Available



Physician's Profile

Full NameTarek S Elkadi
GenderMale
SpecialityAnesthesiology
Experience30 Years
Location360 Broadway, Bangor, Maine
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Tarek S Elkadi graduated from medical school in 1994
  NPI Data:
  • NPI Number: 1245302736
  • Provider Enumeration Date: 11/14/2006
  • Last Update Date: 03/28/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 9436125580
  • Enrollment ID: I20040909000451

Medical Identifiers

Medical identifiers for Tarek S Elkadi such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1245302736NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207L00000XAnesthesiology MD483976 (Pennsylvania)Secondary
207L00000XAnesthesiology MD16476 (Maine)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
St Joseph HospitalBangor, MEHospital
Eastern Maine Medical CenterBangor, MEHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Eastern Maine Medical Center2062315161577
St Joseph Hospital6406766336155
City Of Hope Medical Foundation3779751656686

News Archive

ERC project aims to identify new treatments for prostate cancer

The European Research Council (ERC) has awarded a Consolidator Grant to ICREA researcher Xavier Salvatella, head of the Molecular Biophysics Lab at the Institute for Research in Biomedicine (IRB Barcelona).

Tuberculosis on the rise in the UK

According to health authorities, tuberculosis (TB) – a severe lung infection that has killed millions in the past, is resurfacing again in the UK. Last year the number of cases reached more than 9,000, the highest number for nearly 30 years. The numbers were revealed by the Health Protection Agency in its annual report on tuberculosis this Thursday.

HIV/AIDS efforts among women, girls gaining momentum, but journey 'far from over'

"Global efforts to reach the 'three zeros' for women and girls - zero new HIV infections, zero discrimination and zero AIDS-related deaths - are gaining momentum," Michelle Bachelet, executive director of U.N. Women, Michel Sidibe, executive director of UNAIDS, and Jennifer Gatsi Mallet, executive director of the Namibia Women's Health Network, write in an Inter Press Service opinion piece.

New molecular imaging agent improves diagnosis of recurrent prostate cancer

Findings of a clinical trial reported at SNM's 57th Annual Meeting indicate that a new molecular imaging agent could improve diagnosis of recurrent prostate cancer and determine the best possible course of treatment for patients.

Phase 3 study of INLYTA fails to meet primary endpoint in treatment-naïve patients with RCC

Pfizer Inc. announced today that a Phase 3 study of INLYTA (axitinib) did not meet its primary endpoint of demonstrating statistically significantly longer progression-free survival, versus sorafenib, in treatment-naïve patients with advanced renal cell carcinoma.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Tarek S Elkadi allows following entities to bill medicare on his behalf.
Entity NameEastern Maine Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1790789147
PECOS PAC ID: 2062315161
Enrollment ID: O20040128000088

News Archive

ERC project aims to identify new treatments for prostate cancer

The European Research Council (ERC) has awarded a Consolidator Grant to ICREA researcher Xavier Salvatella, head of the Molecular Biophysics Lab at the Institute for Research in Biomedicine (IRB Barcelona).

Tuberculosis on the rise in the UK

According to health authorities, tuberculosis (TB) – a severe lung infection that has killed millions in the past, is resurfacing again in the UK. Last year the number of cases reached more than 9,000, the highest number for nearly 30 years. The numbers were revealed by the Health Protection Agency in its annual report on tuberculosis this Thursday.

HIV/AIDS efforts among women, girls gaining momentum, but journey 'far from over'

"Global efforts to reach the 'three zeros' for women and girls - zero new HIV infections, zero discrimination and zero AIDS-related deaths - are gaining momentum," Michelle Bachelet, executive director of U.N. Women, Michel Sidibe, executive director of UNAIDS, and Jennifer Gatsi Mallet, executive director of the Namibia Women's Health Network, write in an Inter Press Service opinion piece.

New molecular imaging agent improves diagnosis of recurrent prostate cancer

Findings of a clinical trial reported at SNM's 57th Annual Meeting indicate that a new molecular imaging agent could improve diagnosis of recurrent prostate cancer and determine the best possible course of treatment for patients.

Phase 3 study of INLYTA fails to meet primary endpoint in treatment-naïve patients with RCC

Pfizer Inc. announced today that a Phase 3 study of INLYTA (axitinib) did not meet its primary endpoint of demonstrating statistically significantly longer progression-free survival, versus sorafenib, in treatment-naïve patients with advanced renal cell carcinoma.

Read more Medical News

› Verified 7 days ago

Entity NameAcadia Medical Arts Anesthesia Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1124185376
PECOS PAC ID: 6002802345
Enrollment ID: O20040422000859

News Archive

ERC project aims to identify new treatments for prostate cancer

The European Research Council (ERC) has awarded a Consolidator Grant to ICREA researcher Xavier Salvatella, head of the Molecular Biophysics Lab at the Institute for Research in Biomedicine (IRB Barcelona).

Tuberculosis on the rise in the UK

According to health authorities, tuberculosis (TB) – a severe lung infection that has killed millions in the past, is resurfacing again in the UK. Last year the number of cases reached more than 9,000, the highest number for nearly 30 years. The numbers were revealed by the Health Protection Agency in its annual report on tuberculosis this Thursday.

HIV/AIDS efforts among women, girls gaining momentum, but journey 'far from over'

"Global efforts to reach the 'three zeros' for women and girls - zero new HIV infections, zero discrimination and zero AIDS-related deaths - are gaining momentum," Michelle Bachelet, executive director of U.N. Women, Michel Sidibe, executive director of UNAIDS, and Jennifer Gatsi Mallet, executive director of the Namibia Women's Health Network, write in an Inter Press Service opinion piece.

New molecular imaging agent improves diagnosis of recurrent prostate cancer

Findings of a clinical trial reported at SNM's 57th Annual Meeting indicate that a new molecular imaging agent could improve diagnosis of recurrent prostate cancer and determine the best possible course of treatment for patients.

Phase 3 study of INLYTA fails to meet primary endpoint in treatment-naïve patients with RCC

Pfizer Inc. announced today that a Phase 3 study of INLYTA (axitinib) did not meet its primary endpoint of demonstrating statistically significantly longer progression-free survival, versus sorafenib, in treatment-naïve patients with advanced renal cell carcinoma.

Read more Medical News

› Verified 7 days ago

Entity NameSt Joseph Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1154321545
PECOS PAC ID: 6406766336
Enrollment ID: O20040604000895

News Archive

ERC project aims to identify new treatments for prostate cancer

The European Research Council (ERC) has awarded a Consolidator Grant to ICREA researcher Xavier Salvatella, head of the Molecular Biophysics Lab at the Institute for Research in Biomedicine (IRB Barcelona).

Tuberculosis on the rise in the UK

According to health authorities, tuberculosis (TB) – a severe lung infection that has killed millions in the past, is resurfacing again in the UK. Last year the number of cases reached more than 9,000, the highest number for nearly 30 years. The numbers were revealed by the Health Protection Agency in its annual report on tuberculosis this Thursday.

HIV/AIDS efforts among women, girls gaining momentum, but journey 'far from over'

"Global efforts to reach the 'three zeros' for women and girls - zero new HIV infections, zero discrimination and zero AIDS-related deaths - are gaining momentum," Michelle Bachelet, executive director of U.N. Women, Michel Sidibe, executive director of UNAIDS, and Jennifer Gatsi Mallet, executive director of the Namibia Women's Health Network, write in an Inter Press Service opinion piece.

New molecular imaging agent improves diagnosis of recurrent prostate cancer

Findings of a clinical trial reported at SNM's 57th Annual Meeting indicate that a new molecular imaging agent could improve diagnosis of recurrent prostate cancer and determine the best possible course of treatment for patients.

Phase 3 study of INLYTA fails to meet primary endpoint in treatment-naïve patients with RCC

Pfizer Inc. announced today that a Phase 3 study of INLYTA (axitinib) did not meet its primary endpoint of demonstrating statistically significantly longer progression-free survival, versus sorafenib, in treatment-naïve patients with advanced renal cell carcinoma.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Tarek S Elkadi is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Tarek S Elkadi, MD
C/o St Marys Health System - Provider Enrollment, Po Box 7291,
Lewiston, ME 04243-7291

Ph: (207) 777-8560
Tarek S Elkadi, MD
360 Broadway,
Bangor, ME 04401-3979

Ph: (207) 262-1464

News Archive

ERC project aims to identify new treatments for prostate cancer

The European Research Council (ERC) has awarded a Consolidator Grant to ICREA researcher Xavier Salvatella, head of the Molecular Biophysics Lab at the Institute for Research in Biomedicine (IRB Barcelona).

Tuberculosis on the rise in the UK

According to health authorities, tuberculosis (TB) – a severe lung infection that has killed millions in the past, is resurfacing again in the UK. Last year the number of cases reached more than 9,000, the highest number for nearly 30 years. The numbers were revealed by the Health Protection Agency in its annual report on tuberculosis this Thursday.

HIV/AIDS efforts among women, girls gaining momentum, but journey 'far from over'

"Global efforts to reach the 'three zeros' for women and girls - zero new HIV infections, zero discrimination and zero AIDS-related deaths - are gaining momentum," Michelle Bachelet, executive director of U.N. Women, Michel Sidibe, executive director of UNAIDS, and Jennifer Gatsi Mallet, executive director of the Namibia Women's Health Network, write in an Inter Press Service opinion piece.

New molecular imaging agent improves diagnosis of recurrent prostate cancer

Findings of a clinical trial reported at SNM's 57th Annual Meeting indicate that a new molecular imaging agent could improve diagnosis of recurrent prostate cancer and determine the best possible course of treatment for patients.

Phase 3 study of INLYTA fails to meet primary endpoint in treatment-naïve patients with RCC

Pfizer Inc. announced today that a Phase 3 study of INLYTA (axitinib) did not meet its primary endpoint of demonstrating statistically significantly longer progression-free survival, versus sorafenib, in treatment-naïve patients with advanced renal cell carcinoma.

Read more News

› Verified 7 days ago


Anesthesiology Doctors in Bangor, ME

Dane Hassani, MD
Anesthesiology
Medicare: Accepting Medicare Assignments
Practice Location: 360 Broadway, Bangor, ME 04401
Phone: 207-907-1430    Fax: 207-907-3508
Dr. Dianna Logan Branson, MD ANESTHESIOLOGIST
Anesthesiology
Medicare: Not Enrolled in Medicare
Practice Location: 489 State St, Bangor, ME 04401
Phone: 207-973-7000    Fax: 207-973-5042
Kelly A Morgan, MD
Anesthesiology
Medicare: Accepting Medicare Assignments
Practice Location: 360 Broadway, Bangor, ME 04401
Phone: 207-262-1464    
Dr. Catherine Shields, M.D.
Anesthesiology
Medicare: Not Enrolled in Medicare
Practice Location: 489 State St, Bangor, ME 04401
Phone: 207-973-5918    
David M. Clement, M.D.
Anesthesiology
Medicare: Not Enrolled in Medicare
Practice Location: 360 Broadway, Bangor, ME 04401
Phone: 207-262-1464    
Kishore Anoop Tolani,
Anesthesiology
Medicare: Accepting Medicare Assignments
Practice Location: 489 State St, Bangor, ME 04401
Phone: 207-973-5918    
Haithm A.s. Abdelsalam, M.D
Anesthesiology
Medicare: Accepting Medicare Assignments
Practice Location: 489 State St, Bangor, ME 04401
Phone: 207-275-0987    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.